IDH Present

preview_player
Показать описание

  1. International Dance House
Рекомендации по теме
IDH Present 0:00:41

IDH Present

Vorasidenib in IDH-Mutant 0:02:23

Vorasidenib in IDH-Mutant Glioma | NEJM

The Patient is 0:11:50

The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden

From Mutation to 1:01:30

From Mutation to Treatment: Understanding IDH Inhibitors

NOW Program Educational 1:00:07

NOW Program Educational Webinars: IDH-Mutant Gliomas

IDH || Salary 0:01:07

IDH || Salary Matrix

The prognostic impact 0:02:53

The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS

IDH1 mutation, histology, 0:05:16

IDH1 mutation, histology, and treatment of tissue metabolites in diffuse glioma

Radiomics-based prediction of 0:01:37

Radiomics-based prediction of lymphocyte infiltration in IDH-wildtype glioblastoma

Capitalizing on Personalized 0:57:00

Capitalizing on Personalized Care in IDH Mutant Gliomas

IDH open dag 0:02:20

IDH open dag / IDH view day

IDH, mildly dilated 0:00:11

IDH, mildly dilated LA, RWMA present echocardiography #echocardiography #cardiology

Decitabine, venetoclax, and 0:01:23

Decitabine, venetoclax, and IDH inhibitor in IDH-mutated AML

İON 410. lecture, 0:54:18

İON 410. lecture, Schiff: Management of IDH Mutant Gliomas 08.01.2024

IDK HOW (MUSIC 0:02:56

IDK HOW (MUSIC VIDEO) KARAN AUJLA | FOUR ME EP | LATEST PUNJABI SONGS 2024

IMMUNOHISTOCHEMISTRY ISOCITRATE DEHYDROGENASE 0:04:52

IMMUNOHISTOCHEMISTRY ISOCITRATE DEHYDROGENASE IDH

IDH metabolites induce 0:02:11

IDH metabolites induce a BRCAness that can be exploited by PARP inhibitors

Targeting IDH mutations 0:02:57

Targeting IDH mutations for the treatment of AML

Differentiation Syndrome and 0:09:08

Differentiation Syndrome and IDH Inhibitors in AML

IDH - Mutant 0:15:56

IDH - Mutant Astrocytoma: Update from the 5th Edition WHO Classification of CNS Tumors

GAN-generated histopathology images 0:00:28

GAN-generated histopathology images of IDH-mutant gliomas

IDH inhibition in 0:02:50

IDH inhibition in AML therapy

Are IDH mutations 0:01:11

Are IDH mutations good minimal residual disease (MRD) markers in acute myeloid leukemia (AML)?

Curtis Andrew Lachowiez: 0:04:38

Curtis Andrew Lachowiez: Ivosidenib + Venetoclax and Azacitidine in IDH-Mutated Myeloid Malignancies